Neoadjuvant dual immuno-combination therapy with anti-LAG3 and anti-PD-1 antibodies is feasible and safe for resectable non-small cell lung cancer
@article{JTD96968, author = {Naoki Furuya and Takahiro Homma and Hisashi Saji}, title = {Neoadjuvant dual immuno-combination therapy with anti-LAG3 and anti-PD-1 antibodies is feasible and safe for resectable non-small cell lung cancer}, journal = {Journal of Thoracic Disease}, volume = {17}, number = {2}, year = {2025}, keywords = {}, abstract = {}, issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/96968} }